We are pleased to share that our partner Takeda has received European Commission approval for a new treatment for adults with previously treated metastatic colorectal cancer. It is the first product from our research and discovery engine to be approved in Europe. #ColorectalCancer #mCRC Learn More: https://lnkd.in/gUr7cMxe
Exciting times!
DMPK Consultant at LIYU Pharmaceutical Consulting LLC
2moGreat news Angelique!!